Effect of nasal valve dilation on effective CPAP level in obstructive sleep apnea

Citations of this article
Mendeley users who have this article in their library.


Nasal problems are frequent at high continuous positive airway pressure (CPAP). We hypothesized that a reduction of the nasal resistance reduces CPAP and investigated the effect of a nasal valve dilator (Nozovent®) on CPAP in patients with obstructive steep apnea. In a randomized cross-over design Nozovent®, was inserted in 38 patients during one of two nights using AutoSet T®. CPAP differences > 1 cm H2O were considered as clinically relevant. With Nozovent® the median CPAP pressure was reduced from 8.6 cm H2O to 8.0 H2O (P = 0.023) in all patients, but the number of patients with a reduction of CPAP by 1 cm H2O was not significant. The median CPAP level among 20 patients requiring a CPAP level of above 9 cm H2O was reduced from 10.3 to 9.1 cm H2O, P < 0.05. A clinical improvement with Nozovent® was seen in 10 of 20 patients requiring a pressure of above 9cm H2O compared with 4 of 18 patients who needed lower pressures, P = 0.025. Nozovent® reduces the CPAP level 1 cm H2O in 50% of patients requiring a high pressure (>9cm H2O). Future studies should identify possible patients benefiting from a nasal dilator during CPAP therapy. © 2003 Elsevier Science Ltd. All rights reserved.




Schönhofer, B., Kerl, J., Suchi, S., Köhler, D., & Franklin, K. A. (2003). Effect of nasal valve dilation on effective CPAP level in obstructive sleep apnea. Respiratory Medicine, 97(9), 1001–1005. https://doi.org/10.1016/S0954-6111(03)00125-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free